MANGOCEUTICALS, INC. (MGRX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 168,109 | 109,306 | 133,368 | 163,163 |
| Cost of revenues - related party | 59,346 | 22,505 | 29,192 | 63,706 |
| Cost of revenues | 18,815 | 24,737 | 21,505 | 29,665 |
| Gross profit | 89,948 | 62,064 | 82,671 | 69,792 |
| Advertising and marketing | 258,295 | 281,732 | 251,330 | 229,244 |
| Salary and benefits | 628,343 | 626,598 | 242,941 | 259,105 |
| General and administrative expenses | 1,245,360 | 1,542,444 | 523,855 | 850,704 |
| Stock based compensation | 3,120,445 | 1,045,479 | 567,619 | 859,380 |
| Investor relations | 106,000 | 1,419,000 | 255,000 | 40,000 |
| Total operating expenses | 5,358,443 | 4,915,253 | 1,840,745 | 2,238,433 |
| Loss from operations | -5,268,495 | -4,853,189 | -1,758,074 | -2,168,641 |
| Interest expense | 21,700 | -13,700 | - | - |
| Loss from settlement | -125,625 | - | - | - |
| Interest expense - amortization on discount | - | - | 241,620 | 222,678 |
| Total other expense | -147,325 | 13,700 | -241,620 | -222,678 |
| Loss before income taxes | -5,415,820 | -4,839,489 | -1,999,694 | -2,391,319 |
| Income taxes | - | - | - | - |
| Net loss | -5,415,820 | -4,839,489 | -1,999,694 | -2,391,319 |
| Net loss attributed to non-controlling interest | -2 | -98 | -461 | -340 |
| Net loss attributed to mangoceuticals, inc | -5,415,818 | -4,839,391 | -1,999,233 | -2,390,979 |
| Basic average shares | - | 4,593,063 | 2,013,848 | 26,099,532 |
| Basic loss per share | -0.57 | -1.29 | -0.99 | -0.09 |
| Diluted | 9,983,376 | 4,593,063 | 2,013,848 | 26,099,532 |
| Diluted loss per share | -0.57 | -1.29 | -0.99 | -0.09 |